| NCT ID | NCT07408245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | OvationLab |
| Condition | Biofilm |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-17 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-17 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed by SimplyPERIO (Spectrum Solutions, Salt Lake City, UT).
Eligibility Criteria
Inclusion Criteria: 1. Adult females or males age ≥ 25 years 2. Ability to read and speak English 3. Willingness to take use oral Biocidin as directed for two weeks 4. Willingness not to change any other oral health practices for two weeks 5. Willingness not to change dietary habits for two weeks 6. Willingness to perform a SimplyPERIO oral microbiome test before and after the two-week Biocidin intervention Exclusion Criteria: 1. Current use of oral Biocidin or botanical mouthwash 2. Use of antibiotics within the past 30 days 3. Current use of fixed intraoral orthodontic appliances (e.g., dental braces, fixed retainers, or similar devices) 4. Known allergies to any of the ingredients in the product 5. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 6. Participants unable to provide consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07408245 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, studying Biofilm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07408245 currently recruiting?
Yes, NCT07408245 is actively recruiting participants. Contact the research team at chris@ovationlab.com for enrollment information.
Where is the NCT07408245 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT07408245 clinical trial?
NCT07408245 is sponsored by OvationLab. The trial plans to enroll 60 participants.